Aerovance

Manufacturing · California, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

708 Arimo Ave, Oakland, California, 9461...

Phone Number

(510) 549-5538

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Aerovance

Aerovance is a biopharmaceutical company focused on the development and commercialization of clinical-stage products for respiratory and allergic diseases. The company's goal is to build an integrated company, with acknowledged expertise in leveraging operational partnerships that include the discovery, development and commercialization of novel molecules. Aerovance's lead programs are in development for the treatment of uncontrolled asthma and uncontrolled eczema. Other programs in the pipeline are for cystic fibrosis and chronic obstructive pulmonary disease. Aerovance was spun off from Bayer Healthcare's biotechnology unit in August 2004 and has a proven executive team, experienced in the field of respiratory disease and biologics drug development. The company's venture capital investors are Alta Partners, APAX Partners, Burrill & Company, Clarus Ventures, Lehman Brothers and NGN Capital.Explore more
Popular SearchesAerovance IncAerovanceSIC Code 28,283NAICS Code 32,325Show more

Aerovance Org Chart

PhoneEmail
YY
United States flag for contact location.

Operations Vice President, Clinical Developme...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Aerovance your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Aerovance

Compare insights from companies similar to Aerovance, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Aerovance

<$5M
1-10
Private
-
2004
YY
Yu YenOperations Vice President, Clinical Development
$5.1M
1-10
Private
<$5M
2010
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
2006
N/A
<$5M
1-10
Private
-
2021
<$5M
1-10
Private
-
2012
RR
Robert RubinCo-Founder & Interim Chief Marketing Officer
<$5M
1-10
Private
-
1997
PP
Philip PembertonChief Technical Officer
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Aerovance is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Aerovance is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aerovance.

Aerovance Tech Stack

A closer look at the technologies used by Aerovance

Top Manufacturing Companies

Frequently Asked Questions Regarding Aerovance

What is Aerovance's official website?
Aerovance's official website is www.aerovance.com
What is Aerovance's Revenue?
Aerovance's revenue is <$5 Million
What is Aerovance's SIC code?
Aerovance's SIC: 28,283
What is Aerovance's NAICS code?
Aerovance's NAICS: 32,325
How many employees does Aerovance have?
Aerovance has 1-10 employees
What industry does Aerovance belong to?
Aerovance is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Aerovance competition?
Aerovance top competitors include: Arriva Pharmaceuticals, INVENT Pharmaceuticals, Novoclinica, Kinalta Therapeutics
What technology does Aerovance use?
Some of the popular technologies that Aerovance uses are: Google AdSense, OpenResty, Lua
How do I contact Aerovance?
Aerovance contact info: Phone number: (510) 549-5538 Website: www.aerovance.com
What does Aerovance do?

Aerovance is a biopharmaceutical company focused on the development and commercialization of clinical-stage products for respiratory and allergic diseases. The company's goal is to build an integrated company, with acknowledged expertise in leveraging operational partnerships that include the discovery, development and commercialization of novel mo... lecules. Aerovance's lead programs are in development for the treatment of uncontrolled asthma and uncontrolled eczema. Other programs in the pipeline are for cystic fibrosis and chronic obstructive pulmonary disease. Aerovance was spun off from Bayer Healthcare's biotechnology unit in August 2004 and has a proven executive team, experienced in the field of respiratory disease and biologics drug development. The company's venture capital investors are Alta Partners, APAX Partners, Burrill & Company, Clarus Ventures, Lehman Brothers and NGN Capital.Read More

Is Aerovance a public company?
Aerovance is private company therefore does not currently have an official ticker symbol
See more information about Aerovance

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.